US company Jazz Pharmaceuticals announced Wednesday the appointment of Philip Johnson as Executive Vice President and Chief Financial Officer, effective March 1. Johnson succeeds Renee Gala, who was promoted to President and Chief Operating Officer in October 2023. In his new role, he will oversee financial reporting, accounting, tax, treasury, risk management, financial planning and analysis, information services and facilities. He will also oversee the company’s investor relations and corporate development functions. Johnson, who holds over 35 years of financial experience, spent nearly thre…